Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)

Taiwan · Delayed Price · Currency is TWD

79.00

-1.70 (-2.11%)

Jul 29, 2026, 1:30 PM CST

Foresee Pharmaceuticals Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	401.12	431.27	418.69	195.04	301.51	226.03
Revenue Growth	-5.68%	3.01%	114.67%	-35.31%	33.39%	-1.91%
Gross Profit	261.62	294.22	239.8	113.97	275.97	175.08
Operating Income	-712.55	-862.32	-1,080	-1,008	-469.44	-538.63
Net Income	-183.13	-883.15	-1,081	-1,036	-472.64	-569.27
Earnings Per Share	-1.18	-5.70	-7.87	-8.14	-4.00	-4.85
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Europe	-	46.1	2.59	0.08	39.59
United States	288.4	272.75	409.87	193.95	201.34
China	-	112.42	6.23	1.01	60.58
Total	401.12	431.27	418.69	195.04	301.51

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	891.98	479.52	1,367	1,160	689.51	1,269
Total Debt	399.26	231.74	260.33	228.26	41.32	16.65
Net Cash (Debt)	492.72	247.78	1,107	931.42	648.19	1,252
Net Cash Growth	-43.46%	-77.62%	18.85%	43.70%	-48.24%	-16.05%
Net Cash Per Share	3.17	1.60	8.06	7.32	5.49	10.67

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-729.82	-842.23	-1,174	-887.56	-233.22	-213.33
Capital Expenditures	-47.09	-2.96	-149.59	-46.28	-58.07	-6.86
Free Cash Flow	-776.91	-845.19	-1,323	-933.84	-291.29	-220.19
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	65.22%	68.22%	57.27%	58.44%	91.53%	77.46%
Operating Margin	-177.64%	-199.95%	-257.90%	-516.63%	-155.70%	-238.30%
Pretax Margin	-38.00%	-198.99%	-246.77%	-506.89%	-145.31%	-233.59%
Profit Margin	-45.66%	-204.78%	-258.20%	-531.33%	-156.76%	-251.86%
FCF Margin	-193.68%	-195.98%	-316.07%	-478.80%	-96.61%	-97.42%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	53.91	53.91	53.91	53.91	53.91
PS Ratio	31.03	29.44	28.65	66.97	35.81	62.15